Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis

Fig. 3

Clinical sensitivity and specificity for ctDNA detection. Error bars, binomial 95% confidence intervals. A Subgroup analysis of clinical sensitivity and specificity for ctDNA detection at the first posttreatment time point (ctDNA MRD landmark) for non-small cell lung cancer (NSCLC). B Subgroup analysis of clinical sensitivity and specificity for ctDNA detection with longitudinal monitoring posttreatment (ctDNA Surveillance) for NSCLC

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us